Commission Report Highlights the Potential of Personalised Medicine

The European Commission has published a report which takes stock of the progress made in the field of personalised medicine and the opportunities and challenges associated with its implementation in a healthcare setting. The report focuses on three main areas: 1) the potential for, and issues with, the use of '-omics' technologies in personalised medicine, and the related EU research funding, 2) recent developments in EU legislation for placing medicinal products and devices on the market, and 3) factors affecting the uptake of personalised medicine in health care systems.

The report concludes that personalised medicine has the potential to offer new treatment opportunities for the benefit of patients, including better targeted treatment, avoiding medical errors and reducing adverse reactions to medicines.

Personalised Medicine should be seen as an evolution of medicine, rather than a revolution, and the report recognises the challenges (e.g. in research) associated with its successful entry in healthcare systems. The European Commission will continue to monitor the developments of personalised medicine in the coming years and maintain a fruitful dialogue with stakeholders.

What is personalised medicine?
Although no official definition of personalised medicine exists, it can best be explained as a medical approach which is tailored to the patient or a group of pati! ents - for prevention, prediction and treatment. In other words, it moves away from the common "one size fits all" medical model.

How does the EU support personalised medicine?
Since 2007 the EU has committed over €1 billion of health research funding underpinning the development of personalised medicine through its Seventh Framework Program for Research and Technological Innovation. Going forward, funding under Horizon 2020, the EU's new framework program to be launched at the end of this year, will continue to support this field.

A constructive legal framework has also contributed to the development of personalised medicine. The regulatory framework for pharmaceuticals offers a number of tools and procedures to ensure that medicines placed on the market are of high quality, safety and efficacy. These tools, complemented by scientific guidelines and expert evaluation, have already worked well for innovative products including therapies relevant to personalised medicine.

The ongoing revisions of important pieces of legislation address certain challenges identified in the development of these therapies. The revision of the medical devices legislation will strengthen the legal framework of in vitro diagnostics and introduce a better consultation process for companion diagnostics to assess patient eligibility for treatment with a specific medicinal product. The revision of the Clinical Trials Directive is expected to simplify the conduct of clinical trials and consequently facilitate research in therapies using personalised medicine.

Finally, EU-level cooperation on Health Technology Assessment can help Member States assess the value of using personalised medicine in their health systems, i.e. judge whether their benefits will offset their costs through efficiency gains.

Download: Use of '-omics' technologies in the development of personalised medicine (.pdf, 258 KB).

Download from eHealthNews.eu Portal's mirror: Use of '-omics' technologies in the development of personalised medicine (.pdf, 258 KB).

Most Popular Now

Northern Lincolnshire and Goole NHS Foun…

Northern Lincolnshire and Goole NHS Foundation Trust (NLAG) has launched new NHS App features to transform the way patients access and manage their appointments within the NHS. The programme, known...

Genomics England Deploys Sectra Imaging …

Genomics England has completed installation of an enterprise imaging system that will help to support a world-pioneering initiative for cancer research. The programme is linking whole genome sequencing, pathology and...

Orion Health Strengthens French Business…

Orion Health is strengthening its presence in France with the appointment of digital health industry heavyweight, Tristan Debove, to lead its operations. Tristan Debove has more than 25 years of experience...

AI Approach may Help Detect Alzheimer's …

Although investigators have made strides in detecting signs of Alzheimer's disease using high-quality brain imaging tests collected as part of research studies, a team at Massachusetts General Hospital (MGH) recently...

AI Predicts Cancer Patient Survival by R…

A team of researchers from the University of British Columbia and BC Cancer have developed an artificial intelligence (AI) model that predicts cancer patient survival more accurately and with more...

Virtual Reality Games can be Used as a T…

Virtual reality gamers (VR game) who finished it faster than their fellow gamers also have higher levels of general intelligence and processing capacity. This was the result of a study...

Will Future Computers Run on Human Brain…

A "biocomputer" powered by human brain cells could be developed within our lifetime, according to Johns Hopkins University researchers who expect such technology to exponentially expand the capabilities of modern...

Detecting Anaemia Earlier in Children Us…

Researchers at UCL and University of Ghana have successfully predicted whether children have anaemia using only a set of smartphone images. The study, published in PLOS ONE, brought together researchers and...

AI can Help Optimize CT Scan X-Ray Radia…

Computed tomography (CT) is one of the most powerful and well-established diagnostic tools available to modern medicine. An increasing number of people have been opting for CT scans, raising concerns...

Study Reveals Smartphone Spyware Apps ar…

Smartphone spyware apps that allow people to spy on each other are not only hard to notice and detect, they also will easily leak the sensitive personal information they...

Orion Health Appoints Mark Hindle as Vic…

Orion Health has appointed Mark Hindle as its new vice president for the UK and Ireland. Mark has joined the leading supplier of digital tools to improve healthcare experience from...